Newsletter
Sign up for the Fund's newsletter and get the lastest news, calls and events
| Titel Sort descending | Periode | Program | |
|---|---|---|---|
| SYNFUEL - Sustainable synthetic fuels from biomass gasification and electrolysis | 2015 - 2019 | Grand Solutions
|
|
|
SYNFUEL - Sustainable synthetic fuels from biomass gasification and electrolysis
Period
2015 - 2019
Region
Program
Grand Solutions Area
Energi, Klima og Miljø Investment
Percentage
74.71 Invested
21.2 mill. Budget
28.4 mill. Partners
DTU Energy Conversion, DTU Chemical Engineering, AAU, Institute of Energy Technology, Haldor Topsøe A/S, Topsoe Fuel Cell, DONG Energy, Energinet.dk, Massachusetts Institute of Technology, National Institute of Applied Sciences, North-western University, Chalmers University of Technology, Chinese Academy of Sciences, Department of Energy Engineering Technische Universität Berlin People
Aktiv
Read more about the project
| |||
| Syng&tegn | 2025 - 2026 | Innofounder
|
|
|
Syng&tegn
Period
2025 - 2026
Region
Program
Innofounder Area
Ikke defineret Investment
Percentage
100 Invested
1.1 mill. Budget
1.1 mill. Syng&Tegn – Leg, læring og kulturarv i børnehøjde
Syng&Tegn er en interaktiv app, der kombinerer danske børnesange, kunst og teknologi. Børn kan høre en sang, se en kunstner tegne motiver fra sangen og selv synge, tegne og optage deres egen version. Med hjælp fra kunstig intelligens bliver børnenes tegninger animeret og bragt til live – en sjov og lærerig oplevelse, hvor barnet er aktivt skabende.
Appen tager fat i to samfundsudfordringer: 1) danske børnesange er ved at forsvinde i mængden af udenlandsk digitalt indhold, og 2) børns skærmforbrug mangler ofte kreativt og pædagogisk indhold. Syng&Tegn genopfinder den klassiske sangbog til en digital generation og styrker samtidig børns kreativitet, sprog og kulturelle identitet.
Med støtte fra Innovationsfonden kan vi videreudvikle AI-funktioner, skabe et omfattende bibliotek af sange og sikre høj teknisk og pædagogisk kvalitet. Investeringen vil være afgørende for at bringe Syng&Tegn ud til danske familier og institutioner.
På lang sigt ønsker vi at gøre Syng&Tegn til en digital klassiker i Danmark – og senere udbrede konceptet internationalt med respekt for lokale sprog og traditioner.
Partners
Syng&Tegn Aps People
Syng&Tegn Aps
Read more about the project
| |||
| SYNKLINO - Fighting Viral Diseases by Turning Defense into Offensive Treatments | 2020 - 2021 | Innobooster
|
|
|
SYNKLINO - Fighting Viral Diseases by Turning Defense into Offensive Treatments
Period
2020 - 2021
Region
Region Hovedstaden Program
Innobooster Area
Biotek, Medico og Sundhed Investment
Percentage
33 Invested
455.895 Budget
1.4 mill. Partners
SYNKLINO People
SYNKLINO A/S
Read more about the project
| |||
| Synlighedspilot i Vækstjylland | 2018 - 2019 | Innobooster
|
|
|
Synlighedspilot i Vækstjylland
Period
2018 - 2019
Region
Region Midtjylland Program
Innobooster Area
Ikke defineret Investment
Percentage
100 Invested
150.000 Budget
150.000 Partners
CONPLEKS INNOVATION ApS People
CONPLEKS INNOVATION ApS
Read more about the project
| |||
| Synobody - Nanobodies on demand | 2023 - 2024 | Innofounder
|
|
|
Synobody - Nanobodies on demand
Period
2023 - 2024
Region
Program
Innofounder Area
Ikke defineret Investment
Percentage
100 Invested
760.000 Budget
760.000 Synobody is on a mission to increases accessibility of unique nanobodies for targeted therapeutics, diagnostics, and research tools. Our platform is based on large synthetic nanobody libraries allowing Synobody to reduce prices and turnaround time when identifying nanobodies.
It is integral for Synobody to provide companies and researchers with high quality nanobodies through fast screening, iterative maturation processes and validation tests.
With this vision we aim towards biotech companies worldwide focusing on targeted therapeutics and
diagnostics. Additionally, by identifying Nbs at financially feasible prices we strive to reach academia and SMEs as well.
The Innofounder will allow Synobody to further build our Nb portfolio proving the
platform capability, take on collaborators and costumers, build the team capabilities and to create our website commercially launching the Synobody platform services.
We strongly believe that nanobodies are a tool of great importance in general scientific
research and the advancement of pharmacological and diagnostic technologies. However, the
current economic and temporal barriers and the difficulties in implementing Nbs into lab
protocols are big hindrances in the overall use of this tool.
By breaking these barriers, the Synobody platform is of great value to the biotechnological and
pharmacological sector as it has potential to create scientific growth. Synobody therefore strives to become a key part of the biotech sector.
Partners
Synobody ApS People
Read more about the project
| |||
| Syntax - Adaptiv læring i sprogfagene | 2021 - 2021 | Innobooster
|
|
|
Syntax - Adaptiv læring i sprogfagene
Period
2021 - 2021
Region
Region Hovedstaden Program
Innobooster Area
Ikke defineret Investment
Percentage
23.74 Invested
440.880 Budget
1.9 mill. Partners
August og Hemmingsen APS People
AUGUST OG HEMMINGSEN ApS
Read more about the project
| |||
| Synthetic biology to address complex bottleneck challenges in high-value bioprocesses | 2018 - 2021 | Industrial Researcher
|
|
|
Synthetic biology to address complex bottleneck challenges in high-value bioprocesses
Period
2018 - 2021
Region
Region Hovedstaden Program
Erhvervsforsker Area
Bioressourcer, Fødevarer og Livsstil Investment
Percentage
51.96 Invested
1.1 mill. Budget
2.1 mill. Partners
Technical University of Denmark, Biosyntia ApS People
Biosyntia ApS
Read more about the project
| |||
| Synthetic peptide analogues as targeting and endosomal guiding reagents for gene therapy of autoimmune diseases | 2022 - 2025 | Industrial Researcher
|
|
|
Synthetic peptide analogues as targeting and endosomal guiding reagents for gene therapy of autoimmune diseases
Period
2022 - 2025
Region
Region Hovedstaden Program
Erhvervsforsker Area
Ikke defineret Investment
Percentage
47.15 Invested
1.1 mill. Budget
2.3 mill. Partners
Technical University of Denmark, Novo Nordisk A/S - H-I People
Novo Nordisk A/S - H-I
Read more about the project
| |||
| syntheticAIdata - synthetic data for vision AI | 2024 - 2024 | Innofounder
|
|
|
syntheticAIdata - synthetic data for vision AI
Period
2024 - 2024
Region
Program
Innofounder Area
Ikke defineret Investment
Percentage
100 Invested
430.000 Budget
430.000 syntheticAIdata er en SaaS-løsning, der muliggør effektiv generering af syntetisk data til AI-synsmodeller. Vores platform reducerer omkostninger, sikrer privatlivets fred og fremskynder lanceringen af AI-produkter.
I dagens konkurrenceprægede marked er nøjagtigheden af AI-modeller afgørende. Selvom computer vision-applikationer er almindelige på tværs af industrier, kan det være en udfordrende opgave at træne brugerdefinerede AI-modeller. Processen med at træne disse modeller er ikke kun kostbar, men kræver også betydelige mængder data. For at imødegå disse AI-begrænsninger og fremme værdien af AI-applikationer bør virksomheder skifte til syntetisk data. Gartner forudsiger, at størstedelen af den data, der anvendes i AI inden 2030, vil være syntetiske: kunstigt genereret.
syntheticAIdata tilbyder en cloud-agnostisk løsning, der giver virksomheder mulighed for at producere syntetiske data af høj kvalitet til træning af vision AI-modeller. Vores løsning, der adresserer udfordringen med begrænset data fra den virkelige verden, integreres problemfrit med eksisterende systemer. Den sikrer ikke kun privatlivets fred og overholder lovgivningsmæssig overensstemmelse, men minimerer også overhead og reducerer omkostninger.
Med støtte fra Innovationsfonden kan vi dedikere os fuldt ud til projektet, omdanne vores MVP til et fuldt funktionsdygtigt produkt, tage kunder om bord til feedback, forbedre vores produktudbud og i sidste ende blive markedsledere.
Partners
syntheticAIdata ApS People
Read more about the project
| |||
| SynTIA Synergistic, Transparent and Interpretable Artificial intelligence in Skin Cancer Diagnostics | 2024 - 2028 | Grand Solutions
|
|
|
SynTIA Synergistic, Transparent and Interpretable Artificial intelligence in Skin Cancer Diagnostics
Period
2024 - 2028
Region
Program
Grand Solutions Area
Ikke defineret Investment
Percentage
69.3 Invested
11.6 mill. Budget
16.8 mill. Skin cancers pose significant diagnostic challenges, particularly in telemedicine where physical examination cannot be performed. Dermatologists are compelled to practise defensive medicine due to the fear of overlooking potentially deadly melanomas. This defensive approach results in costly overtreatment of benign lesions and dangerous delays in diagnosing cancers.
SynTIA seeks to develop an artificial intelligence (AI) product that provides synergistic, trustworthy and interpretable diagnostic feedback for tele-dermatologists. SynTIA will guide the dermatologist towards a cost-effective and safe treatment strategy. More specifically, SynTIA will suggest the likely diagnoses, accompanied by the reasoning and confidence behind this analysis. Additionally, SynTIA will show the tumor's potential evolution over the next 3-6 months if left untreated. Finally, SynTIA will offer an analysis of the clinician's bias and likelihood of misdiagnosis, supported by examples of previous similar cases.
The development of SynTIA will rely on data from the AISC-database, which is a large repository of skin lesion images and over 400,000 annotations from the educational Dermloop Learn application. We will use both established and cutting-edge machine learning methodologies, such as Concept Bottleneck and Diffusion Models, to achieve the desired outcomes. The resulting solution will be commercialized within Dermloop, an existing and rapidly scaling telemedical platform for skin diagnostics.
Partners
Technical University of Denmark, Melatech Aps, Copenhagen University Hospital (Rigshospitalet), Herlev Hospital, Odense University Hospital People
Read more about the project
| |||
| SyreN Emission | 2021 - 2021 | Innobooster
|
|
|
SyreN Emission
Period
2021 - 2021
Region
Region Syddanmark Program
Innobooster Area
Ikke defineret Investment
Percentage
33 Invested
449.955 Budget
1.4 mill. Partners
BioCover A/S People
BIOCOVER A/S
Read more about the project
| |||
| System architectures for future mobile networks | 2018 - 2021 | Industrial Researcher
|
|
|
System architectures for future mobile networks
Period
2018 - 2021
Region
Region Hovedstaden Program
Erhvervsforsker Area
Produktion, Materialer, Digitalisering og IKT Investment
Percentage
61.61 Invested
1.1 mill. Budget
1.7 mill. Partners
Technical University of Denmark, Comcores ApS People
Comcores ApS
Read more about the project
| |||
| System til administration af virksomheders ferie og fravær | 2017 - 2017 | Innobooster
|
|
|
System til administration af virksomheders ferie og fravær
Period
2017 - 2017
Region
Region Hovedstaden Program
Innobooster Area
Ikke defineret Investment
Percentage
32.4 Invested
162.000 Budget
500.000 Partners
Away4 IvS People
Away4 ApS
Read more about the project
| |||
| System til distributionsstyring og forretningsekspansion | 2019 - 2019 | Innobooster
|
|
|
System til distributionsstyring og forretningsekspansion
Period
2019 - 2019
Region
Region Hovedstaden Program
Innobooster Area
Ikke defineret Investment
Percentage
33 Invested
290.267 Budget
879.600 Partners
Embrace-it ApS People
Embrace-IT ApS
Read more about the project
| |||
| Systemarkitekt til ny struktur/koncept | 2017 - 2019 | Innobooster
|
|
|
Systemarkitekt til ny struktur/koncept
Period
2017 - 2019
Region
Region Syddanmark Program
Innobooster Area
Ikke defineret Investment
Percentage
100 Invested
300.000 Budget
300.000 Partners
Collectech ApS People
Collectech ApS
Read more about the project
| |||